BioAtla
BCAB
67 hedge funds and large institutions have $14.2M invested in BioAtla in 2024 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 17 closing their positions.
147% more call options, than puts
Call options by funds: $84K | Put options by funds: $34K
24% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 17
6% more funds holding
Funds holding: 63 → 67 (+4)
0.1% more ownership
Funds ownership: 0.73% → 0.83% (+0.1%)
11% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 18
54% less capital invested
Capital invested by funds: $31M → $14.2M (-$16.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$7.72M |
| 2 |
HCM
Highbridge Capital Management
New York
|
+$4.21M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.09M |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$839K |
| 5 |
Renaissance Technologies
New York
|
+$534K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$4.43M |
| 2 |
Millennium Management
New York
|
-$2.63M |
| 3 |
Morgan Stanley
New York
|
-$1.27M |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$902K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$877K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$51.6K | -586 | Closed |
|
77
Simplex Trading
Chicago,
Illinois
| – | -$47.8K | -570 | Closed |
|
|
RI
78
Rinkey Investments
San Diego,
California
| – | -$44.5K | -506 | Closed |
|
|
CPIG
79
Chicago Partners Investment Group
Chicago,
Illinois
| – | -$44.1K | -464 | Closed |
|
|
UBV
80
United Bank (Virginia)
Vienna,
Virginia
| – | -$22.9K | -260 | Closed |
|
|
TCA
81
Transcend Capital Advisors
Madison,
New Jersey
| – | -$17.6K | -200 | Closed |
|
|
CSS
82
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$13.7K | -156 | Closed |
|
|
AAP
83
Arax Advisory Partners
Denver,
Colorado
| – | -$2.98K | -34 | Closed |
|
|
TFA
84
Toth Financial Advisory
Leesburg,
Virginia
| – | -$880 | -10 | Closed |
|
|
NA
85
NewEdge Advisors
New Orleans,
Louisiana
| – | -$18 | – | – |
|
BCAB Hedge Fund Activity: Q4 2024 in Review
67 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in BioAtla (BCAB) for Q4 2024, worth a combined $14.2M — down 54% from $31M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new BCAB positions and 17 closed out — a net gain of 4 holders — while 16 added to existing stakes and 18 trimmed.
The largest buyer was Anson Funds Management, opening a new position worth an estimated $7.72M. The largest seller was Soleus Capital Management, exiting entirely with an estimated $4.43M sold.
- 67 institutional investors held BioAtla (BCAB) as of Q4 2024, up from 63 in Q3 2024.
- Funds reported $14.2M of BioAtla stock for Q4 2024, down 54% quarter-over-quarter.
- 21 funds opened new BioAtla positions in Q4 2024 and 17 closed out, a net change of +4 holders.
- The largest BioAtla buyer in Q4 2024 was Anson Funds Management, an estimated $7.72M added.
- The largest BioAtla seller in Q4 2024 was Soleus Capital Management, an estimated $4.43M sold.
Based on aggregated 13F filings for Q4 2024.